Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses
The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Abstract
The genetic underpinnings of Alzheimer's disease (AD) remain largely elusive despite early successes in identifying three genes that cause early-onset familial AD (those that encode amyloid precursor protein (APP) and the presenilins (PSEN1 and PSEN2)), and one genetic risk factor for late-onset AD (the gene that encodes apolipoprotein E (APOE)). A large number of studies that aimed to help uncover the remaining disease-related loci have been published in recent decades, collectively proposing or refuting the involvement of over 500 different gene candidates. Systematic meta-analyses of these studies currently highlight more than 20 loci that have modest but significant effects on AD risk. This Review discusses the putative pathogenetic roles and common biochemical pathways of some of the most genetically and biologically compelling of these potential AD risk factors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The ε4 allele of the apolipoprotein E (APOE) gene is the major genetic risk factor for AD and dementia with Lewy bodies (DLB) (1, 5, 6), whereas APOE2, a well-established longevity determinant, affords protection against the disease (7, 8).”
From APOE3 -Jacksonville (V236E) variant reduces self-aggregation and risk of dementia (2021) · cites this paper as [1]
In the citing paper
“Familial Alzheimer’s disease, which has an autosomal dominant form of inheritance and early onset, has been associated with mutations in APP, PSEN1 and PSEN2, three genes that are critical for beta amyloid (Aβ) production61.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [61]
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Self-citationAssociation of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891
Candidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577
Self-citationTau-mediated neurodegeneration in Alzheimer’s disease and related disorders
Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174 · cited 1×
“Despite the lack of MAPT mutations in AD, it is likely that tau dysfunction still contributes to AD ris”
BackgroundRogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., et al. (1995) · Nature · doi:10.1038/376775a0 · Cited by 2,052
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857 · cited 1×
“, none of these candidates has been proved to consistently influence disease risk or onset age in more than a handful of sample”
BackgroundSelf-citation
Research works printed but not linked: 1
- Meyer, J. M. & Breitner, J. C. Multiple threshold model for the onset of Alzheimer's disease in the NAS-NRC twin panel. Am. J. Med. Genet. 81, 92–97 (1998). · DOI · Paper page
Cited by
Items 701–754 of 754
Goshadrou, F., Yekta, R. F., Oskouie, A. A., & Eslami, M. (2021) · کومش · doi:10.29252/koomesh.23.1.105
Turmeric products in Alzheimer’s disease
Obulesu, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822448-9.00001-7
Review of the Pathology, Diagnosis and Treatment for Alzheimer's Disease
Liu, X. (2021) · International Conference on Bioinformatics and Intelligent Computing (BIC) · doi:10.1145/3448748.3448767
ZengCheng, F., Li, L., & ZhouJuan, H.-D. (2015)
Age-dependent association of KIBRA gene polymorphism with Alzheimer's disease in Han Chinese
WangLan, H.-F., & Wang, L. (2013)
Functional activation during the stroop task in normal older adults & MCI
Puente, A. N. (2012)
3D microenvironments for in vitro modeling of alzheimer’s disease
Ranjan, V. (2020) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/146832
Prioritizing Disease Genes with Label Propagation on a Heterogeneous Network
Hwang, T.-H., & Kuang, R. (2009) · University of Minnesota Digital Conservancy (University of Minnesota)
Current awareness in geriatric psychiatry
(2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2114
Gambert, S. R. (2020) · Springer eBooks · doi:10.1007/978-3-030-39903-0_1384
The Viability of Treatment Conditioned to the Pathophysiology of Alzheimer’s Disease
de Oliveira, F. F. (2022) · Springer eBooks · doi:10.1007/978-3-030-94383-7_3
Laborchemische Diagnostik und therapeutisches Drugmonitoring
Bondy, B., & Schwarz, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_24
Perneczky, R., & Alexopoulos, P. (2011) · Springer eBooks · doi:10.1007/978-3-642-19795-6_21
Labormedizinische Diagnostik in der Psychiatrie
Schwarz, M. (2016) · Springer eBooks · doi:10.1007/978-3-642-45028-0_26-1
Circulatory Micro RNA in Alzheimers Disease
Singh, V., Chaurasia, R. N., Nath, J., & Deepika, V. (2017) · Research Journal of Life Sciences Bioinformatics Pharmaceutical and Chemical Sciences · doi:10.26479/2017.0303.02
Chaudhari, S. Y., & Jadhav, S. B. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns3.8753
Ye, Q. (2022) · Advances in Social Science, Education and Humanities Research/Advances in social science, education and humanities research · doi:10.2991/assehr.k.220504.328
Nanoskalauntersuchungen vom zellulären Metabolismus mittels Sekundärionen-Massenspektrometrie
Karsten, L. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9484
Grabrucker, S., Marizzoni, M., Silajdžić, E., Lopizzo, N., Mombelli, E., Nicolas, S., Dohm-Hansen, S., Scassellati, C., Moretti, D. V., Rosa, M., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2272240/v1
Invertebrate and Vertebrate Models of Tauopathies
Götz, J., Ittner, L. M., Götz, N. N., Lam, H., & Nicholas, H. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/bk9781849731843-00069
Lateral flow assay for early diagnosis of neurodegenerative disorder
Kumawat, T. K., Parihar, A., Kumawat, V., Sharma, V. L., Pandit, A., Sharma, B., & Biyani, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95539-3.00013-2
Picking the best isoform: PDE4D isoforms as therapeutic targets in Alzheimer’s disease
Paes, D. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20231117dp · Cited by 1
The pathology, diagnosis and treatment of Alzheimer’s disease
Zheng, J. (2023) · Theoretical and Natural Science · doi:10.54254/2753-8818/20/20230741
Bai, B., Vanderwall, D., Li, Y., Wang, X., Poudel, S., Wang, H., Dey, K. K., Chen, P., Yang, K., & Peng, J. (2021) · Figshare · doi:10.6084/m9.figshare.15162179
Adhikari, S. D., Cui, Y., & Wang, J. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae182 · Cited by 1
“Based on the advancement in high-throughput sequencing techniques, specific associated genetic variants, e.g. single-nucleotide polymorphisms (SNPs), have been identified for a large panel of phenotypes using Genome-wide Association Studies (GWAS) [3].”
MethodEryılmaz, I. E., Bakar, M., Egelí, Ü., & Çeçener, G. (2024) · Uludağ Üniversitesi Tıp Fakültesi Dergisi · doi:10.32708/uutfd.1468449
Igwe, M. C. (2024) · doi:10.2196/preprints.65876
Alzheimer’s Disease: Diagnosis and Cure
Rai, V. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815256987124010006
Investigating Neurodegenerative Disorders: Understanding the Complexity of Brain Degeneration
Kishore, B., & Dunuwila, T. S. (2025) · IGI Global eBooks · doi:10.4018/979-8-3693-5464-3.ch008
How and why your gender impacts your risk for dementia?
ZEIDAN, H. M., & ZEIDAN, I. H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21632-9.00004-2
Hasan, S. Y., & Yasir, S. J. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5221429
Abdel-Sater, K. A. (2025) · The Russian Archives of Internal Medicine · doi:10.20514/2226-6704-2025-15-3-165-177
Design of Zwitterionic Conjugated Polymers as Protein Aggregation Inhibitors
Rajan, R., Singh, M. P., Suzuki, K., & Matsumura, K. (2025) · Langmuir · doi:10.1021/acs.langmuir.5c02043
Paplomatas, P., Nikolidaki, M., & Vrahatis, A. G. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-03398-7_51 · Cited by 1
Adult Neurogenesis in Etiology and Pathogenesis of Alzheimer’s Disease
Taupin, P. (2011) · Springer eBooks · doi:10.1007/978-94-007-2016-9_27
Bosch, M. E., Dodiya, H. B., Michalkiewicz, J., Lee, C., Shaik, S. M., Weigle, I. Q., Zhang, C., Osborn, J., Nambiar, A., Patel, P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25237292
Self-citationDrug discovery in plastic surgery
Tang, Y., Wang, J., & Wong, A. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-91168-9.00103-4
Mitchell, L. R., Saville, L., Haight, T., Roy, R., Turner, C., Cheng, Y., Kovalchuk, I., Mohajerani, M. H., & Zovoilis, A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.30.702824
“…processes underlying the cellular response to amyloid beta in neural cells remain elusive, which potentially hampers efforts for better molecular diagnostics and therapeutics for this debilitating disease (Bertram & Tanzi, 2008; Hane et al., 2017; Korczyn, 2012; Toledo, Shaw, & Trojanowski, 2013).”
Alzheimer’s disease and other dementias
Khandelwal, C., & Kaufer, D. (2014) · Elsevier eBooks · doi:10.1016/b978-0-323-08936-4.00026-1 · Cited by 1
Nouvelles méthodes électrochimiques pour le criblage d’inhibiteurs de transcétolases
Aymard, C. (2018) · theses.fr (ABES) · doi:10.70675/47be351bzc9a1z4e08z8502zead21e001030 · Cited by 2
Fernandez, A. (2021) · theses.fr (ABES) · doi:10.70675/7cb066b8zf242z426dz938fzfc129ca91b30
Miller, S. J., Prokopenko, D., Bai, P., Mondal, P., Scott, A., Zhang, W., Gomm, A., Zhang, S., Child, D. D., Shen, N., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71271 · Cited by 1
“2,7,8 Mounting genetic, biochemical, and molecular biological evidence shows that there is a strong association of A β accumulation in AD and that A β deposition may be a critical pathogenetic event leading to AD.”
Self-citationLaborchemische Diagnostik, Biomarker
Schwarz, M., Wiltfang, J., & Hansen, N. (2026) · Springer Reference Medizin · doi:10.1007/978-3-642-45028-0_26-2
Yu, J., Xu, M. M., Wu, X., Kang, W.-B., Zou, W.-Y., Liu, Q., Zhang, D., & Yao, Y. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03664-7
Differential A-to-I editing of SINE B2 RNAs unveils an epitranscriptome response to Aβ neurotoxicity
Mitchell, L., Saville, L., Gollen, B., Haight, T., Roy, R., Turner, C., Cheng, Y., Kovalchuk, I., Mohajerani, M. H., & Zovoilis, A. (2026) · Life Science Alliance · doi:10.26508/lsa.202603668
“…of the molecular processes underlying the cellular response to amyloid beta in neural cells remain elusive, which potentially hampers efforts for better molecular diagnostics and therapeutics for this debilitating disease (Bertram & Tanzi, 2008; Korczyn, 2012; Toledo et al, 2013; Hane et al, 2017).”
Rationally Designed Peptides and Peptoids as Inhibitors of Amyloid-β (Aβ) Aggregation
Huang, X., Ma, S., Li, X., & Pan, J. (2026) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6c00145
Laborchemische Diagnostik, Biomarker
Schwarz, M., Wiltfang, J., Hansen, N., & Teupser, D. (2026) · Springer Reference Medizin · doi:10.1007/978-3-642-45028-0_26-3
Genetische Polymorphismen und Progressionsgeschwindigkeit der Alzheimer-Demenz
Wolff, M. (2013) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4096
Human Stem Cell Approaches to Understanding and Treating Alzheimer’s Disease
Goldstein, L. S. B. (2013) · Research and perspectives in neurosciences · doi:10.1007/978-3-642-36648-2_7
Network-based learning algorithms for understanding human disease
Hwang, T. H. (2011) · University of Minnesota Digital Conservancy (University of Minnesota)
Metadata
- Authors
- Bertram, L., & Tanzi, R. E.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Corresponding author
- Bertram, Lars
- Venue
- Nature Reviews Neuroscience
- Published
- 2008-10
- Volume
- 9
- Issue
- 10
- Pages
- 768-778
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2018342879
- Cited by
- 747
- References
- 113
- Citations by year
- 2026: 12 · 2025: 16 · 2024: 25 · 2023: 21 · 2022: 33 · 2021: 26 · 2020: 29 · 2019: 34 · 2018: 41 · 2017: 46 · 2016: 37 · 2015: 41 · 2014: 46 · 2013: 59 · 2012: 62
- FWCI
- 7.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (5R01-AG23667, R01AG023667)
- National Institute of Mental Health (5R37MH60009, R37MH060009)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- Alzheimer's disease genetics, genetic risk factors, candidate genes, meta-analysis, amyloid precursor protein, presenilin 1, presenilin 2, apolipoprotein E, early-onset familial Alzheimer's disease, late-onset Alzheimer's disease, disease pathology, metabolic pathways
- MeSH terms
- Alzheimer Disease, Animals, Apolipoproteins E, Brain Chemistry, Humans, Mutation, Risk Factors, Meta-Analysis as Topic, Amyloid beta-Protein Precursor, Genetic Predisposition to Disease, Presenilins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.